quintiles today introduced allume™, page-9

Listed on April the 16th. But the listing took over 18 months, when everyone thought it would be a straightforward process. "When is the listing?" was asked so many times it became a running joke. I used to own PRR shares but sold out at around 28cents, and I don't follow the stock as closely anymore, although I think it has amazing potential. It just has a looong way to go and requires higher rigour of assessment compared to Vitrogrow. Both products tap into massive markets.

Anyway, I'm atill in with TIS and I'm not so sure the announcement of approval will be the magic bullet to blue sky many think it will be. Sales figures from the first quarter and the rate of conversion of interest in the product to sales will be, although there may be some short term strength after the announcement.